Today: 9 June 2026
SEBI listing-rule revamp sparks MSEI unlisted share rally and a hiring rush at NSE, BSE
20 January 2026
2 mins read

SEBI listing-rule revamp sparks MSEI unlisted share rally and a hiring rush at NSE, BSE

Mumbai, January 20, 2026, 11:39 IST

  • SEBI has launched a review of LODR, the key listing and disclosure regulations governing India’s publicly traded companies
  • Unlisted shares of MSEI have jumped following approval of a liquidity scheme and renewed optimism about a revival
  • NSE, BSE, and other market infrastructure companies are hiring senior executives to comply with stricter governance rules

India’s market watchdog, the Securities and Exchange Board of India (SEBI), has kicked off a review of its Listing Obligations and Disclosure Requirements (LODR), sources told Business Standard late Sunday. This has put the Metropolitan Stock Exchange of India (MSEI) back under the spotlight, with its unlisted shares more than doubling recently amid chatter about a third exchange and a broader boost linked to the National Stock Exchange’s upcoming IPO.

LODR serves as the primary guideline for disclosures and corporate governance among listed companies, detailing what information must be disclosed and when. Any overhaul could impact compliance efforts, adjust the timing for releasing price-sensitive data, and modify SEBI’s approach to enforcing governance violations.

The timing is crucial as SEBI pushes ahead with a broader overhaul of market regulations. Companies and intermediaries are closely watching to see if the regulator will cut down on overlaps or just shift them around.

The committee tasked with the LODR exercise convened for the first time in early January, the report noted. It positioned the move within a wider overhaul that’s already reshaped mutual fund and stock-broker regulations, while takeover rules and settlement norms remain on the agenda.

Market watchers say MSEI’s fresh bid comes after SEBI greenlit a liquidity enhancement scheme (LES). The plan uses incentives to push market makers and traders to post quotes, boosting cash-market volumes. Supported by brokers like Zerodha and Groww, MSEI aims to get approval to launch derivatives—contracts linked to stocks or indexes—once trading picks up. Meanwhile, major market infrastructure institutions (MIIs) such as NSE and BSE have ramped up senior hires to comply with a SEBI governance directive, according to Whalesbook.

SEBI chairman Tuhin Kanta Pandey described the LODR overhaul as a gradual process, not a quick fix. “We will have lots of consultation and put out a consultation paper and it will take some time,” he said at a CII event in November. The Economic Times

India’s equity market is largely controlled by NSE and BSE. If MSEI moves into derivatives, it will enter a fiercely competitive space where liquidity—characterized by tight bid-ask spreads and deep order books—often determines the winners and losers.

Regulatory approvals and executive hires don’t ensure trading volumes. MSEI’s unlisted shares have seen wild swings in the past. The exchange’s comeback depends on brokers and investors sticking around after incentives dry up—and on SEBI approving new products.

Listed companies, brokers, and investors are currently focused on the upcoming consultation paper, which will detail SEBI’s proposed changes to LODR and the timeline for their rollout. Until that document is released, the market is reacting more to the broad theme than the specifics.

Stock Market Today

  • Croda's FTSE 100 Stock Slides 70% but Reset Strategy Could Spur Recovery
    June 9, 2026, 11:02 AM EDT. Croda (LSE: CRDA), once a high-flying FTSE 100 growth stock driven by vaccine-related lipid demand, has seen its shares plunge about 70% from peak levels. The specialty chemicals firm is now executing a turnaround strategy, focusing on core markets such as Beauty, Pharma, and Agriculture to leverage pricing power and stable demand. Management aims to tackle rising costs and improve margins by simplifying operations, sharpening innovation, and boosting efficiency with digital tools and AI. Early signs of recovery are visible in the Beauty segment, where faster ingredient commercialization and regional targeting are helping to rebuild momentum. However, risks remain around execution and potential demand slowdowns, leaving investors uncertain if the reset can fully restore profitability and growth momentum.

Latest articles

Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

9 June 2026
Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
Reddit Shares Pop After Wall Street Sees the Right Ad Signal

Reddit Shares Pop After Wall Street Sees the Right Ad Signal

9 June 2026
Reddit shares surged 6.6% to $182.44 after Cleveland Research and Piper Sandler cited stronger ad demand and raised revenue forecasts, with Cleveland noting 45% of advertisers beat ROI targets in Q2 and Reddit taking ad share from rivals, but risks remain around user growth, AI search traffic, and high valuation.
Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
STMicroelectronics stock slides nearly 5% on Trump Greenland tariff threat; what to watch next
Previous Story

STMicroelectronics stock slides nearly 5% on Trump Greenland tariff threat; what to watch next

DBS share price dips after CGS downgrade, with Feb. 9 results the next test
Next Story

DBS share price dips after CGS downgrade, with Feb. 9 results the next test

Go toTop